Skip to content Skip to sidebar Skip to footer
Menu
Menu
Newsletter
Menu
Newsletter
Healthcare Stocks
Mesoblast (ASX:MSB) Delivers 60% Jump in Ryoncil Sales, Strengthening Commercial Momentum
Mesoblast Lifts on Ryoncil Growth Mesoblast (ASX:MSB) delivered a very strong performance this morning following a positive guidance update for Ryoncil, its cell-based therapy and the only FDA approved treatment for steroid refractory acute graft versus host disease. This is a serious and often life-threatening condition with limited treatment options, which helps explain the growing…
January 9, 20260Comments
Alcidion
Tech Stocks Technology
Alcidion (ASX:ALC) Surges 15% After Winning Preferred Supplier Role for A$35M NHS Contract
Alcidion Secures Preferred Supplier Status for Major UK EPR System Worth Over A$35M Alcidion shares rose 15% today following a strong commercial announcement that the company has been selected as the preferred supplier for a new electronic patient record system at University Hospitals Sussex. While the contract has not yet been formally signed, Alcidion has…
January 8, 20260Comments
Elsight
Tech Stocks Technology
Elsight (ASX:ELS) Breaks New Ground, A$682K US Order Marks First Civilian Contract Win
From Battlefield to Main Street Elsight (ASX:ELS) has secured its first commercial order in calendar year 2026 from a US public safety customer, with a purchase order value of approximately A$682k. This is an important step for the business as it demonstrates early traction beyond pure defence markets and highlights the potential to broaden its…
January 8, 20260Comments
DroneShield
Tech Stocks Technology
DroneShield’s European Order Book Tops A$111M, Is the Stock a Buy Ahead of the EU $800B Defence Spending Boom?
Europe Reloads as €150B Defence Spend Sparks Fresh Growth Momentum DroneShield (ASX:DRO) has staged a sharp recovery, rising more than 100% over the past month. For those who have been following our coverage, we have written extensively on the company’s growth trajectory and long term opportunity. In our recent analysis, we focused on the underlying fundamentals…
January 7, 20260Comments
CurveBeam AI
Tech Stocks Technology
CurveBeam AI (ASX:CVB) Jumps 20% as China Greenlights A$4M Equity Injection
CurveBeam AI Gets the Green Light CurveBeam AI (ASX:CVB) shares surged 20% today after the company received formal China ODI approval for its previously announced strategic investment supporting long term expansion into China. Importantly, this is not a new transaction. Rather, it represents a key regulatory greenlight that allows Chinese capital to legally move offshore…
January 7, 20260Comments
4dmedical
Tech Stocks Technology
4DMedical Hits All-Time High as UC San Diego Begins Commercial Use of CT VQ
4DMedical Takes Flight 4DMedical (ASX:4DX) announced today that UC San Diego Health has commenced commercial clinical use of its CT VQ software, a meaningful milestone that further validates the company’s technology. Following the announcement, the stock reached a new all time high of A$4.70 per share. This marks the company’s fourth major academic medical centre…
January 7, 20260Comments
Adisyn
Semiconductor stocks Tech Stocks Technology
Adisyn’s (ASX:AI1) Graphene Interconnects for Computer Chips Pass the Heat Test
Adisyn Hits Development Milestone Adisyn (ASX: AI1), through its subsidiary 2D Generation, announced today that it has successfully deposited a graphene-like carbon layer using an atomic layer deposition (ALD) tool at low temperatures. This is a meaningful technical milestone. To understand why this matters, we will look at how modern semiconductor chips are manufactured and why…
January 6, 20260Comments

Independent ASX research and stock analysis. Actionable investment ideas on ASX-listed stocks from analysts who call it straight.

Sectors
Quick Links
Learn

Stocks Down Under (Pitt Street Research AFSL 1265112) provides actionable investment ideas on ASX-listed stocks. This content provides general information only and does not constitute financial advice. Always do your own research before making investment decisions. © 2026 Stock Down Under. All Rights Reserved.

the Kick-ass Multipurpose WordPress Theme

Investing in the Year of the Rat
2020, the Golden Year
Market trouble spots to avoid in 2020
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here